chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood creatinine increased, Blood lactic acid normal, Brain natriuretic peptide, COVID-19
Clinical narrative: Date of Admission: 1/9/2022   Date of Discharge: 1/14/2022   Issues to be Addressed at Follow-up:   Acute Hypoxic Respiratory Failure iso covid-19, IGG-4 related ILD - self-isolate for total of 20 days from sx onset (12/28) - s/p remdesivir x5d, decadron 6mg PO x4d  - cefepime/azithro (1/9-1/12) -- > levaquin 750mg PO q24hr (1/12-1/16) to cover for superimposed bacterial pna - 0LPM O2 at rest, 2-4L w/ exertion 77yo male hx of IgG4 related ILD (not on home O2, on chronic pirfenidone, Cellcept), with recent PFTs (2/2021) showing restrictive ventillatory defect, normal TLC,DLCO (improved from prior). Flu-like symptom onset 12/28, +COVID. Symptoms initially improved, however 3 days prior to admission had worsening SOB. Met sepsis criteria (fever, tachypnea, hypoxia to 84% w/ exertion, requiring 2L NC) on admission. No leukocytosis, however, patient on immunosuppressive therapy.  CXR showed diffuse patchy and interstitial opacifications as well as consolidation of medial L lung base. CT Chest w/ new patchy multifocal infiltrates and L medial lobe infiltrate, no PE. Etiology of AHRF suspected from COVID vs component of ILD flare. Concern for superimposed pna given immunosuppressed status. Started on remdesivir 1/10, decadron 1/11 (d/w Dr.) for covid, cefepime/azithro -- > levaquin for superimposed bacterial pna. Continued pirfenidone/cellcept for ILD. Also noted to have +legionella Ab 1:256, though unclear if current vs prior infection. Prior to discharge, trialed ambulation in room, desatted to 85%, although patient reported feeling better than recent baseline prior to covid infection. Stable for discharge home w/ home O2 2-4L.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  Severe sepsis wo acute organ dysfunction due to covid pna
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Computerised tomogram thorax abnormal, Dyspnoea, Dyspnoea exertional, Fibrin D dimer
Clinical narrative: Date of Admission: 1/9/2022   Date of Discharge: 1/14/2022   Issues to be Addressed at Follow-up:   Acute Hypoxic Respiratory Failure iso covid-19, IGG-4 related ILD - self-isolate for total of 20 days from sx onset (12/28) - s/p remdesivir x5d, decadron 6mg PO x4d  - cefepime/azithro (1/9-1/12) -- > levaquin 750mg PO q24hr (1/12-1/16) to cover for superimposed bacterial pna - 0LPM O2 at rest, 2-4L w/ exertion 77yo male hx of IgG4 related ILD (not on home O2, on chronic pirfenidone, Cellcept), with recent PFTs (2/2021) showing restrictive ventillatory defect, normal TLC,DLCO (improved from prior). Flu-like symptom onset 12/28, +COVID. Symptoms initially improved, however 3 days prior to admission had worsening SOB. Met sepsis criteria (fever, tachypnea, hypoxia to 84% w/ exertion, requiring 2L NC) on admission. No leukocytosis, however, patient on immunosuppressive therapy.  CXR showed diffuse patchy and interstitial opacifications as well as consolidation of medial L lung base. CT Chest w/ new patchy multifocal infiltrates and L medial lobe infiltrate, no PE. Etiology of AHRF suspected from COVID vs component of ILD flare. Concern for superimposed pna given immunosuppressed status. Started on remdesivir 1/10, decadron 1/11 (d/w Dr.) for covid, cefepime/azithro -- > levaquin for superimposed bacterial pna. Continued pirfenidone/cellcept for ILD. Also noted to have +legionella Ab 1:256, though unclear if current vs prior infection. Prior to discharge, trialed ambulation in room, desatted to 85%, although patient reported feeling better than recent baseline prior to covid infection. Stable for discharge home w/ home O2 2-4L.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  Severe sepsis wo acute organ dysfunction due to covid pna
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Hypoxia, Influenza like illness, Influenza virus test negative, Interstitial lung disease
Clinical narrative: Date of Admission: 1/9/2022   Date of Discharge: 1/14/2022   Issues to be Addressed at Follow-up:   Acute Hypoxic Respiratory Failure iso covid-19, IGG-4 related ILD - self-isolate for total of 20 days from sx onset (12/28) - s/p remdesivir x5d, decadron 6mg PO x4d  - cefepime/azithro (1/9-1/12) -- > levaquin 750mg PO q24hr (1/12-1/16) to cover for superimposed bacterial pna - 0LPM O2 at rest, 2-4L w/ exertion 77yo male hx of IgG4 related ILD (not on home O2, on chronic pirfenidone, Cellcept), with recent PFTs (2/2021) showing restrictive ventillatory defect, normal TLC,DLCO (improved from prior). Flu-like symptom onset 12/28, +COVID. Symptoms initially improved, however 3 days prior to admission had worsening SOB. Met sepsis criteria (fever, tachypnea, hypoxia to 84% w/ exertion, requiring 2L NC) on admission. No leukocytosis, however, patient on immunosuppressive therapy.  CXR showed diffuse patchy and interstitial opacifications as well as consolidation of medial L lung base. CT Chest w/ new patchy multifocal infiltrates and L medial lobe infiltrate, no PE. Etiology of AHRF suspected from COVID vs component of ILD flare. Concern for superimposed pna given immunosuppressed status. Started on remdesivir 1/10, decadron 1/11 (d/w Dr.) for covid, cefepime/azithro -- > levaquin for superimposed bacterial pna. Continued pirfenidone/cellcept for ILD. Also noted to have +legionella Ab 1:256, though unclear if current vs prior infection. Prior to discharge, trialed ambulation in room, desatted to 85%, although patient reported feeling better than recent baseline prior to covid infection. Stable for discharge home w/ home O2 2-4L.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  Severe sepsis wo acute organ dysfunction due to covid pna
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Legionella test positive, Lung consolidation, Lung diffusion test, Lung infiltration, Lung opacity
Clinical narrative: Date of Admission: 1/9/2022   Date of Discharge: 1/14/2022   Issues to be Addressed at Follow-up:   Acute Hypoxic Respiratory Failure iso covid-19, IGG-4 related ILD - self-isolate for total of 20 days from sx onset (12/28) - s/p remdesivir x5d, decadron 6mg PO x4d  - cefepime/azithro (1/9-1/12) -- > levaquin 750mg PO q24hr (1/12-1/16) to cover for superimposed bacterial pna - 0LPM O2 at rest, 2-4L w/ exertion 77yo male hx of IgG4 related ILD (not on home O2, on chronic pirfenidone, Cellcept), with recent PFTs (2/2021) showing restrictive ventillatory defect, normal TLC,DLCO (improved from prior). Flu-like symptom onset 12/28, +COVID. Symptoms initially improved, however 3 days prior to admission had worsening SOB. Met sepsis criteria (fever, tachypnea, hypoxia to 84% w/ exertion, requiring 2L NC) on admission. No leukocytosis, however, patient on immunosuppressive therapy.  CXR showed diffuse patchy and interstitial opacifications as well as consolidation of medial L lung base. CT Chest w/ new patchy multifocal infiltrates and L medial lobe infiltrate, no PE. Etiology of AHRF suspected from COVID vs component of ILD flare. Concern for superimposed pna given immunosuppressed status. Started on remdesivir 1/10, decadron 1/11 (d/w Dr.) for covid, cefepime/azithro -- > levaquin for superimposed bacterial pna. Continued pirfenidone/cellcept for ILD. Also noted to have +legionella Ab 1:256, though unclear if current vs prior infection. Prior to discharge, trialed ambulation in room, desatted to 85%, although patient reported feeling better than recent baseline prior to covid infection. Stable for discharge home w/ home O2 2-4L.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  Severe sepsis wo acute organ dysfunction due to covid pna
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphocyte count normal, Normocytic anaemia, Oxygen saturation decreased, Pneumonia bacterial, Pyrexia
Clinical narrative: Date of Admission: 1/9/2022   Date of Discharge: 1/14/2022   Issues to be Addressed at Follow-up:   Acute Hypoxic Respiratory Failure iso covid-19, IGG-4 related ILD - self-isolate for total of 20 days from sx onset (12/28) - s/p remdesivir x5d, decadron 6mg PO x4d  - cefepime/azithro (1/9-1/12) -- > levaquin 750mg PO q24hr (1/12-1/16) to cover for superimposed bacterial pna - 0LPM O2 at rest, 2-4L w/ exertion 77yo male hx of IgG4 related ILD (not on home O2, on chronic pirfenidone, Cellcept), with recent PFTs (2/2021) showing restrictive ventillatory defect, normal TLC,DLCO (improved from prior). Flu-like symptom onset 12/28, +COVID. Symptoms initially improved, however 3 days prior to admission had worsening SOB. Met sepsis criteria (fever, tachypnea, hypoxia to 84% w/ exertion, requiring 2L NC) on admission. No leukocytosis, however, patient on immunosuppressive therapy.  CXR showed diffuse patchy and interstitial opacifications as well as consolidation of medial L lung base. CT Chest w/ new patchy multifocal infiltrates and L medial lobe infiltrate, no PE. Etiology of AHRF suspected from COVID vs component of ILD flare. Concern for superimposed pna given immunosuppressed status. Started on remdesivir 1/10, decadron 1/11 (d/w Dr.) for covid, cefepime/azithro -- > levaquin for superimposed bacterial pna. Continued pirfenidone/cellcept for ILD. Also noted to have +legionella Ab 1:256, though unclear if current vs prior infection. Prior to discharge, trialed ambulation in room, desatted to 85%, although patient reported feeling better than recent baseline prior to covid infection. Stable for discharge home w/ home O2 2-4L.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  Severe sepsis wo acute organ dysfunction due to covid pna
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Superinfection, Tachypnoea, Troponin normal
Clinical narrative: Date of Admission: 1/9/2022   Date of Discharge: 1/14/2022   Issues to be Addressed at Follow-up:   Acute Hypoxic Respiratory Failure iso covid-19, IGG-4 related ILD - self-isolate for total of 20 days from sx onset (12/28) - s/p remdesivir x5d, decadron 6mg PO x4d  - cefepime/azithro (1/9-1/12) -- > levaquin 750mg PO q24hr (1/12-1/16) to cover for superimposed bacterial pna - 0LPM O2 at rest, 2-4L w/ exertion 77yo male hx of IgG4 related ILD (not on home O2, on chronic pirfenidone, Cellcept), with recent PFTs (2/2021) showing restrictive ventillatory defect, normal TLC,DLCO (improved from prior). Flu-like symptom onset 12/28, +COVID. Symptoms initially improved, however 3 days prior to admission had worsening SOB. Met sepsis criteria (fever, tachypnea, hypoxia to 84% w/ exertion, requiring 2L NC) on admission. No leukocytosis, however, patient on immunosuppressive therapy.  CXR showed diffuse patchy and interstitial opacifications as well as consolidation of medial L lung base. CT Chest w/ new patchy multifocal infiltrates and L medial lobe infiltrate, no PE. Etiology of AHRF suspected from COVID vs component of ILD flare. Concern for superimposed pna given immunosuppressed status. Started on remdesivir 1/10, decadron 1/11 (d/w Dr.) for covid, cefepime/azithro -- > levaquin for superimposed bacterial pna. Continued pirfenidone/cellcept for ILD. Also noted to have +legionella Ab 1:256, though unclear if current vs prior infection. Prior to discharge, trialed ambulation in room, desatted to 85%, although patient reported feeling better than recent baseline prior to covid infection. Stable for discharge home w/ home O2 2-4L.    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  Severe sepsis wo acute organ dysfunction due to covid pna
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Underage before the 5/12/21 approval for Pfizer vaccine  Guardian elected to falsify DOB
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Anticoagulant therapy, Back pain, Deep vein thrombosis, Dyspnoea
Clinical narrative: On 10/17/21 I woke up with left leg pain, swelling and redness, went to the ER and was diagnosed with deep vein thrombosis. I had also been experiencing intermittent upper back stabbing pain and shortness of breath which was diagnosed as pulmonary embolism. I was prescribed blood thinner to treat it
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Pulmonary embolism, Ultrasound Doppler abnormal
Clinical narrative: On 10/17/21 I woke up with left leg pain, swelling and redness, went to the ER and was diagnosed with deep vein thrombosis. I had also been experiencing intermittent upper back stabbing pain and shortness of breath which was diagnosed as pulmonary embolism. I was prescribed blood thinner to treat it
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Malaise, SARS-CoV-2 test positive
Clinical narrative: Patient came to ED with shortness of breath.  Patient admitted with positive Covid and Covid symptoms.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: itchy, hives all over head (not face), chest, back, legs, arms for 3 days. responded fairly well to benadryl. resolved completely.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Pneumonia, SARS-CoV-2 test positive
Clinical narrative: pneumonia
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient administered 0.5mL instead of 0.25mL booster 3rd dose. Patient called on 1/18/2022 and denied any problems since vaccination. A letter was sent to patient informing of dose administered.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 2/1/2022 18-year-old female received booster shy of 5-month CDC guideline recommendation.  EMT-C16023 miscalculated date and administered booster 14 days before due date.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: fever, cough, short of breath
Age: 5.0
Sex: M
Vaccine: COVID19, DTAPIPV, UNK
Symptoms: Decreased appetite, Dizziness, Erythema, Peripheral swelling, Pyrexia
Clinical narrative: 1/31/22 at 5:00 pm - Left arm is red, swollen and hot to the touch.  2/1/22 at 7:00 am - Arm still red, swollen, and warm. Also has fever, decreased appetite, and feels ?dizzy. ?
Age: 5.0
Sex: M
Vaccine: COVID19, DTAPIPV, UNK
Symptoms: Skin warm
Clinical narrative: 1/31/22 at 5:00 pm - Left arm is red, swollen and hot to the touch.  2/1/22 at 7:00 am - Arm still red, swollen, and warm. Also has fever, decreased appetite, and feels ?dizzy. ?
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Diarrhoea, Dysmenorrhoea, Migraine, Uterine dilation and curettage
Clinical narrative: On December 10, 2 days after my booster shot I had Menstrual cramps, Lower back pain, Migraine, Diarrhea. I have been in menopause for 5 years but the next day experienced vaginal bleeding which was similar to a regular menstrual cycle  when I had it before. The symptoms stated above lasted except for the bleeding lasted for approximately 3-4 days and the vaginal bleeding lasted for 10 days. December 30 - I went to see an OB-GYN to assess if this was something serious - procedures were done (Uterus Scraping, etc.) and the test was normal - no cancer related issues. There was no prescription given.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: On December 10, 2 days after my booster shot I had Menstrual cramps, Lower back pain, Migraine, Diarrhea. I have been in menopause for 5 years but the next day experienced vaginal bleeding which was similar to a regular menstrual cycle  when I had it before. The symptoms stated above lasted except for the bleeding lasted for approximately 3-4 days and the vaginal bleeding lasted for 10 days. December 30 - I went to see an OB-GYN to assess if this was something serious - procedures were done (Uterus Scraping, etc.) and the test was normal - no cancer related issues. There was no prescription given.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Death, Headache, Oropharyngeal pain
Clinical narrative: pt to ED with c/o headache, frontal sinus congest, sore throat, mild cough, denies SOB; positive for COVID; per death certificate pt died in the ED
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sinus congestion
Clinical narrative: pt to ED with c/o headache, frontal sinus congest, sore throat, mild cough, denies SOB; positive for COVID; per death certificate pt died in the ED
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: General symptom
Clinical narrative: Onset of symptoms 9/5/21
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Cognitive disorder, Hyperthyroidism, Lymphadenopathy
Clinical narrative: back and hip pain, enlarged lymph nodes, cognitive changes, thyrotoxicosis
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Myalgia, SARS-CoV-2 test positive
Clinical narrative: chills, myalgias, mild cough
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Incorrect dose administered, Malaise, Product preparation issue
Clinical narrative: Pharmacist failed to dilute the Covid19 Pfizer pediatric age 5-11 vaccine.  Pt received 0.2ml of undiluted vaccine. The pharmacist on duty realized her mistake and called the patient's mom shortly thereafter. The patient did not experience any immediate symptoms, but did have a fever of 101.8 the following day that resolved on its own without the use of medication. He did also experience fatigue, malaise and loss of appetite on 1/30/22 (the day after the error), but felt well the next day and was able to attend school.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Pharmacist failed to dilute the Covid19 Pfizer pediatric age 5-11 vaccine.  Pt received 0.2ml of undiluted vaccine. The pharmacist on duty realized her mistake and called the patient's mom shortly thereafter. The patient did not experience any immediate symptoms, but did have a fever of 101.8 the following day that resolved on its own without the use of medication. He did also experience fatigue, malaise and loss of appetite on 1/30/22 (the day after the error), but felt well the next day and was able to attend school.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: PEDS Pfizer dose was administered w/o dilution.
Age: 31.0
Sex: M
Vaccine: UNK
Symptoms: Incorrect dose administered, Syringe issue
Clinical narrative: On 1/10/22 patient did not receive COVID-19 Moderna booster as requested and was injected with empty syringe in error.  Patient was contacted and booster vaccination TBD.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient came in for his 2nd dose COVID vaccine. The chart was preloaded and had the wrong Lot Number in it. I read the lot number and grabbed the corresponding vaccine and administered it. Patient tolerated fine, no adverse effects. CDC has been notified.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: General symptom
Clinical narrative: Onset of symptoms 9/5/21
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Alphavirus test, Back pain, Biopsy bone abnormal, Bone marrow necrosis, Dengue virus test
Clinical narrative: 1/29/2022-ITP: Patient presents with severe low back pain and petechial rash on admit platelets were 10 and rash on extremities and buccal mucosa.  Started pulse dexamethasone and 40mg daily for 4 days then 10 mg prednisone daily. Received IVIG one time.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Electromyogram normal, HIV test negative, Immunoglobulin therapy, Laboratory test normal, Myalgia
Clinical narrative: 1/29/2022-ITP: Patient presents with severe low back pain and petechial rash on admit platelets were 10 and rash on extremities and buccal mucosa.  Started pulse dexamethasone and 40mg daily for 4 days then 10 mg prednisone daily. Received IVIG one time.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Oral mucosal eruption, Petechiae, Platelet count decreased, Rash, Smear test
Clinical narrative: 1/29/2022-ITP: Patient presents with severe low back pain and petechial rash on admit platelets were 10 and rash on extremities and buccal mucosa.  Started pulse dexamethasone and 40mg daily for 4 days then 10 mg prednisone daily. Received IVIG one time.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Alanine aminotransferase increased, Back pain, Blood alkaline phosphatase increased, Blood lactate dehydrogenase increased, C-reactive protein increased
Clinical narrative: 1/29/2022-ITP: Patient presents with severe low back pain and petechial rash on admit platelets were 10 and rash on extremities and buccal mucosa.  Started pulse dexamethasone and 40mg daily for 4 days then 10 mg prednisone daily. Received IVIG one time.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Chest pain, Helicobacter infection, Helicobacter test positive, Immunology test normal, Multisystem inflammatory syndrome
Clinical narrative: 1/29/2022-ITP: Patient presents with severe low back pain and petechial rash on admit platelets were 10 and rash on extremities and buccal mucosa.  Started pulse dexamethasone and 40mg daily for 4 days then 10 mg prednisone daily. Received IVIG one time.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Myalgia, Platelet count decreased, Red blood cell sedimentation rate increased, Serum ferritin increased
Clinical narrative: 1/29/2022-ITP: Patient presents with severe low back pain and petechial rash on admit platelets were 10 and rash on extremities and buccal mucosa.  Started pulse dexamethasone and 40mg daily for 4 days then 10 mg prednisone daily. Received IVIG one time.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Alphavirus test, Aspiration bone marrow, Biopsy bone marrow abnormal, Blood fibrinogen normal, Blood lactate dehydrogenase decreased
Clinical narrative: 1/29/2022-ITP: Patient presents with severe low back pain and petechial rash on admit platelets were 10 and rash on extremities and buccal mucosa.  Started pulse dexamethasone and 40mg daily for 4 days then 10 mg prednisone daily. Received IVIG one time.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Blood smear test abnormal, Bone marrow necrosis, Chest pain, Coagulation test normal, Dengue virus test negative
Clinical narrative: 1/29/2022-ITP: Patient presents with severe low back pain and petechial rash on admit platelets were 10 and rash on extremities and buccal mucosa.  Started pulse dexamethasone and 40mg daily for 4 days then 10 mg prednisone daily. Received IVIG one time.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: HIV test negative, Haptoglobin normal, Hepatitis viral test negative, Immune thrombocytopenia, Myalgia
Clinical narrative: 1/29/2022-ITP: Patient presents with severe low back pain and petechial rash on admit platelets were 10 and rash on extremities and buccal mucosa.  Started pulse dexamethasone and 40mg daily for 4 days then 10 mg prednisone daily. Received IVIG one time.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Petechiae, Platelet count decreased, Red blood cell schistocytes present, Systemic inflammatory response syndrome
Clinical narrative: 1/29/2022-ITP: Patient presents with severe low back pain and petechial rash on admit platelets were 10 and rash on extremities and buccal mucosa.  Started pulse dexamethasone and 40mg daily for 4 days then 10 mg prednisone daily. Received IVIG one time.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Syncope, Unresponsive to stimuli
Clinical narrative: Client presented to vaccine site with her mother on 1/22/2022 to receive the COVID Pfizer Booster dose. RN vaccinated client with the COVID Pfizer Booster dose (Lot# FJ6369) in the L arm while sitting upright at 1340. At approximately 1341 the client stated "i'm feeling dizzy" and  RN called for help. RN stabilized the client in the chair as she fainted and Lead RN assisted in stimulating the client. Client had a strong pulse and patent airway. RN assessed client was unresponsive to stimuli for approximately 2 seconds. Client did not fall out of chair and did not sustain any injuries. When client became responsive to stimuli, RN assessed client was A&O x4 and reoriented client to the room. EMT provided client with water and took client's vitals. Vitals at 1342 were BP in R arm sitting upright 138/90, HR 93, and SPO2 99%. Client's mother reported "she starts to shake even talking about the vaccine" and stated that the client has a history of anxiety with needles. RN reported to Lead RN that the client did not disclose history of syncope with needles prior to vaccination.  Client reported her last intake was carne asada fries at approximately 1230. Client denied SOB, pain, nausea, or changes in vision. Client reported mild dizziness. EMT and Lead RN assisted in transferring the client to lay down cot in observation area. EMT took vitals at 1355 with BP 132/94, HR 98, and SPO2 98%. At 1355 the client reported she was "not really dizzy anymore" and "a little lightheaded". Lead RN reviewed ER precautions and when to f/u with PCP with client and her mother. RN observed a steady and symmetrical gait as client walked around in observation. Client left the vaccine site with her mother who drove her at approximately 1410.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Pneumonia, SARS-CoV-2 test positive
Clinical narrative: pneumonia
Age: 54.0
Sex: M
Vaccine: TYP
Symptoms: Wrong product administered
Clinical narrative: Pt was given two doses of Typhoid vaccine instead of 1 Typhoid and 1 Meningococcal vaccine. Mixed up the vaccine and
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: The patient was vaccinated at 10:55. He was observed for 15 minutes s/p vaccination with no complications of shortness of breath. The patient was active and dancing during the observation period. The patient was discharged with his mother ambulating  independently.   At approximately 11: 16 am the patient returned with his mother who states she saw fine bumps on the back of his neck. The patient was wearing a new mask received from Pharmacy prior to coming to the clinic. The fine bumps were noted along the strap line of the mask on the back of his neck. The patient denies shortness of breath; pain; itching. No swelling or redness was noted. Mom stated after returning that the patient had a rash after receiving his first dose of the Pfizer vaccination.   She also stated he has a history of ADHD and was receiving medication. In addition she stated he had seasonal allergies and received Benadryl in the past. She did not report these findings on the initial interview or with the second interview conducted with the nurse.    The patient was noted to not be in distress. Monitoring was continued. The patient was able to leave with his mother ambulating independently without complications or distress.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Underage before the 5/12 approval for Pfizer vaccine  Suspected falsification of DOB ? guardian ?unsure? how DOB error occurred
Age: 29.0
Sex: F
Vaccine: UNK
Symptoms: Incorrect dose administered, Syringe issue
Clinical narrative: On 1/10/22 patient did not receive COVID-19 Moderna booster as requested and was injected with empty syringe in error.  Patient was  contacted and booster vaccination TBD.
Age: 71.0
Sex: F
Vaccine: UNK
Symptoms: Arthralgia, Paralysis
Clinical narrative: Extreme rapid pain in vulnerable joints. Joints were temporarily frozen (?paralyzed?) and could not move Lasted through day but improved following morning.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Mobility decreased, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: . Patient received Janssen booster shot on 12/27/2021 and stated she had a swollen and achy arm the same day. Two weeks later patient stated she had diarrhea for four days then it went away and then occurred again one week later. She also stated she had a fever 2 days after receiving the vaccine. Throughout the course of events patient said her swollen arm continued and worsened and has difficulty maintaining full range of motion. She met with physician who advised the pharmacy to report side effects.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative
Clinical narrative: . Patient received Janssen booster shot on 12/27/2021 and stated she had a swollen and achy arm the same day. Two weeks later patient stated she had diarrhea for four days then it went away and then occurred again one week later. She also stated she had a fever 2 days after receiving the vaccine. Throughout the course of events patient said her swollen arm continued and worsened and has difficulty maintaining full range of motion. She met with physician who advised the pharmacy to report side effects.
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: C-reactive protein increased, Cardiac imaging procedure abnormal, Electrocardiogram abnormal, Electrocardiogram normal, Fibrosis
Clinical narrative: Patient received pfizer vaccine on 4/21/21 and 5/19/21 and the booster dose with moderna vaccine on 12/1/21. patient presented to hospital with pleuritic chest pain, troponin leak and EKG changes most c/f myopericarditis secondary to covid booster. troponin: 686-> 791 -> 880, initial EKG: diffuse STE, not seeing any PR depressions, repeat ECG improved. Covid negative. CRP 24.3. Cardiac MRI revealed myopericarditis and patient was treated with ibuprofen and colchicine and symptoms completely resolved within 2 days.
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myocarditis, Pleuritic pain, SARS-CoV-2 test negative, Scar, Troponin
Clinical narrative: Patient received pfizer vaccine on 4/21/21 and 5/19/21 and the booster dose with moderna vaccine on 12/1/21. patient presented to hospital with pleuritic chest pain, troponin leak and EKG changes most c/f myopericarditis secondary to covid booster. troponin: 686-> 791 -> 880, initial EKG: diffuse STE, not seeing any PR depressions, repeat ECG improved. Covid negative. CRP 24.3. Cardiac MRI revealed myopericarditis and patient was treated with ibuprofen and colchicine and symptoms completely resolved within 2 days.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: unknown
Age: 22.0
Sex: F
Vaccine: FLUR4
Symptoms: No adverse event
Clinical narrative: No adverse reactions. Patient tolerated fine. CDC and providers notified.
Age: 66.0
Sex: F
Vaccine: PPV, VARZOS
Symptoms: Expired product administered
Clinical narrative: PNEUMOVAX 23 OUTDATED (EXP 1/28/22)
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect route of product administration, Pain in extremity
Clinical narrative: Patient stated her vaccine was given high up on her shoulder and she experienced arm pain for about 2 months
Age: 28.0
Sex: F
Vaccine: UNK
Symptoms: Incorrect dose administered, Syringe issue
Clinical narrative: On 1/10/22 patient did not receive COVID-19 Moderna booster as requested and was injected with empty syringe in error.  Patient was  contacted and booster vaccination TBD.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Nausea, Palpitations
Clinical narrative: Approximately 20 minutes after receiving vaccination patient begin to have nausea, feeling of heart racing and chest discomfort
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: Administered undiluted pediatric Pfizer. Per mom no symptoms.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Unknown.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Patient received a gray top pfizer booster vaccine, that was inadvertently diluted.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Abortion spontaneous
Clinical narrative: Miscarriage (two times).
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Underage before the 5/12/21 approval for Pfizer vaccine  Suspected falsification of DOB ? unable to contact guardian
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: General symptom
Clinical narrative: symptom onset 11/18/21
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenitis, Pain, Painful respiration, Pleurisy
Clinical narrative: Inflamed lymph node and pain moving arm. On Jan 27 went to urgent care with pain inhaling, diagnosed with pleurisy.
Age: 21.0
Sex: M
Vaccine: UNK
Symptoms: Incorrect dose administered, Syringe issue
Clinical narrative: On 1/10/22 patient did not receive COVID-19 Moderna booster as requested and was injected with empty syringe in error.  Patient was  contacted and booster vaccination TBD.
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: ADMINISTERED PEDS PFIZER W/O DILUTION NO Sx per mom
Age: 33.0
Sex: F
Vaccine: MMR, MMR
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus
Clinical narrative: Patient received MMR #1 in the right arm on 12/21/2021 at 1635 without reaction or side effect.  She received MMR #2 in  the left arm on 1/21/2022.  On 1/24/2022, she developed itching, 8/10 pain, erythema and deep induration to her right arm (MMR #1) injection site.  By 1/31/2022, her right arm pain decreased to 0-1/10 and itching and erythema resolved.  Induration remained measuring approximately 1 cm x .5 cm.  Otherwise,  history and clinic exam negative.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: unknown
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Tinnitus, X-ray
Clinical narrative: I have been experiencing a lot of joint pain and tinnitus. The joint pain seems to move around my body. When one place stops hurting another will start to hurt. It started with my right hip. The pain generally happens on the right side of my body. I went and saw my PCP and he referred me to physical therapy and told me to take anti-inflammatories. After my hip pain improved, my shoulder and elbow started to hurt. I feel that physical therapy is helping. I am not blaming the vaccine, but this did occur after receiving my booster. If we are in need to get another booster, I will still get it. I am very thankful for those that are doing all of this work with the vaccines.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea
Clinical narrative: Patient came to ED with shortness of breath and dyspnea.  Patient admitted with Covid.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Interchange of vaccine products
Clinical narrative: Individual scheduled for a Second dose Pfizer/BioNTech on 01/31/22 after receiving first dose Moderna on 12/16/21. Patient was administered Pfizer/BioNTech 0.3 ml IM in Left Deltoid on 01/31/22.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: Patient was given undiluted Pfizer age 5-11 vaccine. Pharmacist forgot to dilute the kid Pfizer with 1.3ml of diluent. Pharmacist withdrew 0.2 ml of undiluted vaccine.  This pharmacist then gave the vaccine to a second pharmacist who then administered to the child.
Age: 33.0
Sex: M
Vaccine: UNK
Symptoms: Incorrect dose administered, Syringe issue
Clinical narrative: On 1/10/22 patient did not receive COVID-19 Moderna booster as requested and was injected with empty syringe in error.  Patient was  contacted and booster vaccination TBD.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: RECEIVED PEDS PFIZER DOSE W/O DILUTION PER MOM JUST ARM DISCOMFORT
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient received a full 0.5 ml dose of the 4th booster dose for an immunocompromised patient
Age: 55.0
Sex: F
Vaccine: UNK
Symptoms: Inappropriate schedule of product administration
Clinical narrative: vaccine given too early
Age: 38.0
Sex: M
Vaccine: UNK
Symptoms: Incorrect dose administered, Syringe issue
Clinical narrative: On 1/10/22 patient did not receive COVID-19 Moderna booster as requested and was injected with empty syringe in error.  Patient was  contacted and booster vaccination TBD.
Age: 58.0
Sex: M
Vaccine: FLU4, VARZOS
Symptoms: Anaemia, Back pain, Blood blister, Blood folate, Chills
Clinical narrative: burning foot pain, erythema, fever, chills, dizzy, nausea, headache, blood blister on face, fatigue, burning pain on back
Age: 58.0
Sex: M
Vaccine: FLU4, VARZOS
Symptoms: Dizziness, Erythema, Fatigue, Full blood count normal, Headache
Clinical narrative: burning foot pain, erythema, fever, chills, dizzy, nausea, headache, blood blister on face, fatigue, burning pain on back
Age: 58.0
Sex: M
Vaccine: FLU4, VARZOS
Symptoms: Metabolic function test, Nausea, Pain, Pain in extremity, Pyrexia
Clinical narrative: burning foot pain, erythema, fever, chills, dizzy, nausea, headache, blood blister on face, fatigue, burning pain on back
Age: 58.0
Sex: M
Vaccine: FLU4, VARZOS
Symptoms: Vitamin B12
Clinical narrative: burning foot pain, erythema, fever, chills, dizzy, nausea, headache, blood blister on face, fatigue, burning pain on back
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product preparation error
Clinical narrative: ADMINISTERED PFIZER PEDS W/O DILUTION NO Sx reported
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, Nausea, Vomiting
Clinical narrative: Patient sent to ED from primary care physician for nausea/vomiting.  Patient admitted to hospital with Covid.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Urticaria, Vomiting
Clinical narrative: Hives, nausea (5+ days started 1/27/2022) and vomiting (3 times since 1/27/2022). As of 2/01/2022: Hives showing improvement. Nausea showing improvement. Vomiting Last time 1/31/2022.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Antinuclear antibody, Arthralgia, C-reactive protein increased, Eosinophil count, Fatigue
Clinical narrative: Serum-sickness type reaction, occurring 12 days after vaccine administration. Symptoms included: fever, arthralgias, fatigue, diffuse urticarial rash.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Laboratory test, Pyrexia, Red blood cell sedimentation rate increased, Urine analysis
Clinical narrative: Serum-sickness type reaction, occurring 12 days after vaccine administration. Symptoms included: fever, arthralgias, fatigue, diffuse urticarial rash.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, White blood cell count increased
Clinical narrative: Serum-sickness type reaction, occurring 12 days after vaccine administration. Symptoms included: fever, arthralgias, fatigue, diffuse urticarial rash.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Influenza A virus test positive, Influenza B virus test, Peripheral swelling, Pruritus
Clinical narrative: On the evening of the 3rd vax, 12/15/2020 started feeling itchy on left wrist, then the next morning his hand was swollen to 3 times the size it normally is and had hives all over body. Went to Urgent Care where they gave blood tests for covid, and, influenza A and B. Tested positive for Influenza A. Did have the Flu vax in 8/2020, and didn't have any reaction. Never  had a reaction to it. After he got the Booster Moderna vax is when he tested positive for Influenza A.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Urticaria
Clinical narrative: On the evening of the 3rd vax, 12/15/2020 started feeling itchy on left wrist, then the next morning his hand was swollen to 3 times the size it normally is and had hives all over body. Went to Urgent Care where they gave blood tests for covid, and, influenza A and B. Tested positive for Influenza A. Did have the Flu vax in 8/2020, and didn't have any reaction. Never  had a reaction to it. After he got the Booster Moderna vax is when he tested positive for Influenza A.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose normal, Fall, Syncope
Clinical narrative: Patient fainted and fell out of chair within 5 minutes of receiving vaccine
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: ADAMTS13 activity normal, Heparin-induced thrombocytopenia test positive, Thrombocytopenia
Clinical narrative: Thrombocytopenia-- no intervention except labs (but required admission to hospital)
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Pt had Monoclonial Antibody Tx only 83 days prior to booster, instead of the reccommended 90 days. Pt was given "booster dose of 0.25mL". Pt has been contacted and reports No Adverse Reactions and has no concerns. Writer called the CDC, was given no indication to revaccinate pt.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Condition aggravated, Herpes zoster, Interchange of vaccine products, Menstruation irregular
Clinical narrative: felt pain on the back of my lower neck/upper back. I thought I had a spider bite or some kind of bite. It was painful and then became itchy. After a few more days I started to feel pain on my skin. it started from the spot on the back of my neck and worked it's way toward my right shoulder and eventually across to the middle of my chest. in a gradual pattern over a few weeks the pain turned to burning and then itching and then looked like a rash. The pain and burning was so bad it was hard to wear a shirt and hard to shower. I went to the doctor to see if I was having an allergic reaction to something. They said it was a mild case of shingles and would go away in a few more weeks.  The bumps eventually turned to little scabs. I no longer have pain but still have a bunch of the scabs. They are now only slightly bothersome and seem to be clearing up.  Also, my periods are always regular but after my second shot(moderna) and again after my booster(pfizer) I had an extra period between my cycles. Also, my 11 year old daughter who has not yet begun menstruating got a period few weeks after her second shot. She has not had another period since.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain, Pain of skin, Pruritus, Rash
Clinical narrative: felt pain on the back of my lower neck/upper back. I thought I had a spider bite or some kind of bite. It was painful and then became itchy. After a few more days I started to feel pain on my skin. it started from the spot on the back of my neck and worked it's way toward my right shoulder and eventually across to the middle of my chest. in a gradual pattern over a few weeks the pain turned to burning and then itching and then looked like a rash. The pain and burning was so bad it was hard to wear a shirt and hard to shower. I went to the doctor to see if I was having an allergic reaction to something. They said it was a mild case of shingles and would go away in a few more weeks.  The bumps eventually turned to little scabs. I no longer have pain but still have a bunch of the scabs. They are now only slightly bothersome and seem to be clearing up.  Also, my periods are always regular but after my second shot(moderna) and again after my booster(pfizer) I had an extra period between my cycles. Also, my 11 year old daughter who has not yet begun menstruating got a period few weeks after her second shot. She has not had another period since.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Scab
Clinical narrative: felt pain on the back of my lower neck/upper back. I thought I had a spider bite or some kind of bite. It was painful and then became itchy. After a few more days I started to feel pain on my skin. it started from the spot on the back of my neck and worked it's way toward my right shoulder and eventually across to the middle of my chest. in a gradual pattern over a few weeks the pain turned to burning and then itching and then looked like a rash. The pain and burning was so bad it was hard to wear a shirt and hard to shower. I went to the doctor to see if I was having an allergic reaction to something. They said it was a mild case of shingles and would go away in a few more weeks.  The bumps eventually turned to little scabs. I no longer have pain but still have a bunch of the scabs. They are now only slightly bothersome and seem to be clearing up.  Also, my periods are always regular but after my second shot(moderna) and again after my booster(pfizer) I had an extra period between my cycles. Also, my 11 year old daughter who has not yet begun menstruating got a period few weeks after her second shot. She has not had another period since.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Biopsy skin, Blood test, Dermatitis contact, Rash, Rash erythematous
Clinical narrative: Developed itchy red rash on trunk which is still active after treatment by two dermatologists, allergist and primary doctor
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash pruritic, Skin test
Clinical narrative: Developed itchy red rash on trunk which is still active after treatment by two dermatologists, allergist and primary doctor
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dermatitis contact, Erythema, Hypersensitivity, Rash pruritic
Clinical narrative: Developed itchy red rash on trunk which is still active after treatment by two dermatologists, allergist and primary doctor
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: Administered (PEDS) Pfizer dose w/o dilution. Unable to reach family.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Underage before the 5/12/21 approval for Pfizer vaccine  Guardian elected to falsify DOB
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Blood creatinine increased, C-reactive protein increased, Chondrocalcinosis pyrophosphate, Diarrhoea
Clinical narrative: Admitted to hospital with diarrhea, acute renal failure, pseudo-gout, later followed by diagnosis of Rheumatoid arthritis
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate increased, Rheumatoid arthritis, Rheumatoid factor
Clinical narrative: Admitted to hospital with diarrhea, acute renal failure, pseudo-gout, later followed by diagnosis of Rheumatoid arthritis
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy, Erythema, Feeling hot, Pain in extremity, Peripheral swelling
Clinical narrative: After receiving the vaccine I was diagnosed with Pityriasis Rosea. I had the rash for 30 days then it went away. I also had arm pain through out the month, and it has been ongoing. I also had burning, hot, skin for about a week on my stomach and upper chest. I was prescribed a cream. I had a red swollen arm for a week.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pityriasis rosea, Skin burning sensation
Clinical narrative: After receiving the vaccine I was diagnosed with Pityriasis Rosea. I had the rash for 30 days then it went away. I also had arm pain through out the month, and it has been ongoing. I also had burning, hot, skin for about a week on my stomach and upper chest. I was prescribed a cream. I had a red swollen arm for a week.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder, Vaginal haemorrhage
Clinical narrative: With each Moderna vaccine or booster I've received I have had vaginal bleeding about 5 days after even though it is in the middle of my cycle and I'm not due for a period.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Patient received gray top pfizer booster thatw as inadvertently diluted with 1.8 ml sodium chloride.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: COVID-19 vaccine Pfizer (for 5-11 year olds) given to a 12 year old patient